Trial intelligence / Profile preview

SMART Combined With S-1/DDP for Elderly Esophageal Squamous Cell Carcinoma

NCT02606916Phase 2Completed

Sponsor
Sun Yat-sen University
Start
Jul 2015
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tegafur, cisplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Sun Yat-sen University. Started Jul 2015; status: completed.

02

Drugs

tegafurcisplatin
03

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)

Beyond the preview

Go deeper on NCT02606916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02606916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call